Methylphenidate Hydrochloride 62037-0734-01
- Manufacturer
- Actavis Pharma, Inc.
- Dosage Form
- Tablet, Film Coated, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- March 4, 2019
- Listing Expires
- December 31, 2027
- Application
- ANDA076772
Active Ingredients
| Ingredient | Strength |
|---|---|
| Methylphenidate Hydrochloride | 27 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Selected Package
62037-0734-01Selected100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (62037-734-01)